Patent Expiry

Patent/Exclusivity Expiry: HALAVEN

January 8, 2027

Company: ALX ONCOLOGY HOLDINGS INC (ALXO)
Drug: HALAVEN

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start Free Full Calendar

Patent/Exclusivity Expiry: HALAVEN — ALXO Patent Expiry | BioSniper